A115480 Stock Overview
Engages in the manufacture and sale of defibrillators worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
CU Medical Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩746.00 |
| 52 Week High | ₩1,010.00 |
| 52 Week Low | ₩644.00 |
| Beta | 0.52 |
| 11 Month Change | -5.57% |
| 3 Month Change | 10.36% |
| 1 Year Change | -14.25% |
| 33 Year Change | -29.62% |
| 5 Year Change | -71.31% |
| Change since IPO | -91.89% |
Recent News & Updates
Shareholder Returns
| A115480 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -1.7% | -3.1% | -1.2% |
| 1Y | -14.3% | 15.3% | 4.8% |
Return vs Industry: A115480 underperformed the KR Medical Equipment industry which returned 15.3% over the past year.
Return vs Market: A115480 underperformed the KR Market which returned 4.8% over the past year.
Price Volatility
| A115480 volatility | |
|---|---|
| A115480 Average Weekly Movement | 4.5% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in KR Market | 12.2% |
| 10% least volatile stocks in KR Market | 3.5% |
Stable Share Price: A115480 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A115480's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 116 | Hyung-Soo Kim | cu911.com |
CU Medical Systems, Inc. engages in the manufacture and sale of defibrillators worldwide. It offers automatic external defibrillators (AEDs), automated CPR devices, heart rate monitors, defibrillator trainer, and functional electrical stimulation products. The company was founded in 2001 and is headquartered in Wonju-si, South Korea.
CU Medical Systems, Inc. Fundamentals Summary
| A115480 fundamental statistics | |
|---|---|
| Market cap | ₩35.90b |
| Earnings (TTM) | -₩6.59b |
| Revenue (TTM) | ₩39.32b |
0.9x
P/S Ratio-5.4x
P/E RatioIs A115480 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A115480 income statement (TTM) | |
|---|---|
| Revenue | ₩39.32b |
| Cost of Revenue | ₩19.33b |
| Gross Profit | ₩19.99b |
| Other Expenses | ₩26.58b |
| Earnings | -₩6.59b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -136.90 |
| Gross Margin | 50.84% |
| Net Profit Margin | -16.75% |
| Debt/Equity Ratio | 64.0% |
How did A115480 perform over the long term?
See historical performance and comparison